Alireza Atri, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 60 | 2025 | 8758 | 4.360 |
Why?
|
Cholinesterase Inhibitors | 8 | 2019 | 241 | 2.240 |
Why?
|
Dementia | 13 | 2024 | 2741 | 1.520 |
Why?
|
Memantine | 7 | 2019 | 111 | 1.320 |
Why?
|
Neuropsychological Tests | 12 | 2024 | 7148 | 1.130 |
Why?
|
Lewy Body Disease | 3 | 2024 | 253 | 1.100 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2019 | 452 | 0.870 |
Why?
|
Parkinson Disease | 6 | 2024 | 2896 | 0.860 |
Why?
|
Neurodegenerative Diseases | 3 | 2023 | 1094 | 0.770 |
Why?
|
Benzylamines | 3 | 2019 | 251 | 0.730 |
Why?
|
Indans | 4 | 2018 | 92 | 0.630 |
Why?
|
Disclosure | 3 | 2024 | 754 | 0.620 |
Why?
|
Cognition Disorders | 7 | 2019 | 3985 | 0.590 |
Why?
|
Serotonin Antagonists | 1 | 2018 | 147 | 0.570 |
Why?
|
Amyloid | 8 | 2024 | 854 | 0.550 |
Why?
|
Galantamine | 2 | 2018 | 33 | 0.530 |
Why?
|
Amyloidogenic Proteins | 6 | 2023 | 154 | 0.460 |
Why?
|
Indoles | 3 | 2019 | 1836 | 0.440 |
Why?
|
Dopamine Agents | 4 | 2019 | 190 | 0.440 |
Why?
|
Nootropic Agents | 4 | 2019 | 159 | 0.420 |
Why?
|
Cost of Illness | 2 | 2019 | 1959 | 0.400 |
Why?
|
Phenylcarbamates | 1 | 2011 | 38 | 0.390 |
Why?
|
Caregivers | 4 | 2023 | 2308 | 0.380 |
Why?
|
Memory | 6 | 2016 | 2210 | 0.370 |
Why?
|
Disease Progression | 9 | 2024 | 13677 | 0.360 |
Why?
|
Piperidines | 4 | 2018 | 1669 | 0.360 |
Why?
|
Amyloid beta-Peptides | 11 | 2024 | 3912 | 0.340 |
Why?
|
Hippocampus | 2 | 2014 | 3786 | 0.340 |
Why?
|
Mental Recall | 1 | 2016 | 1226 | 0.340 |
Why?
|
Psychotherapy | 1 | 2019 | 1654 | 0.340 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 1002 | 0.340 |
Why?
|
Autopsy | 5 | 2024 | 1013 | 0.330 |
Why?
|
Drug Therapy, Combination | 4 | 2019 | 6320 | 0.320 |
Why?
|
Executive Function | 2 | 2024 | 1405 | 0.320 |
Why?
|
Olfactory Bulb | 3 | 2024 | 198 | 0.310 |
Why?
|
Cognition | 7 | 2024 | 7080 | 0.300 |
Why?
|
Brain Mapping | 7 | 2016 | 6740 | 0.280 |
Why?
|
Lewy Bodies | 2 | 2024 | 141 | 0.280 |
Why?
|
tau Proteins | 8 | 2024 | 2145 | 0.280 |
Why?
|
Humans | 78 | 2025 | 768887 | 0.280 |
Why?
|
Health Care Costs | 1 | 2019 | 3270 | 0.250 |
Why?
|
Decision Making | 1 | 2019 | 3952 | 0.240 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7860 | 0.240 |
Why?
|
Communication | 1 | 2019 | 3908 | 0.240 |
Why?
|
Brain | 13 | 2024 | 27476 | 0.230 |
Why?
|
Proactive Inhibition | 1 | 2004 | 2 | 0.230 |
Why?
|
Word Association Tests | 1 | 2004 | 52 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 12 | 2024 | 36861 | 0.220 |
Why?
|
Nerve Net | 2 | 2014 | 2361 | 0.220 |
Why?
|
Oxygen | 3 | 2012 | 4273 | 0.220 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2003 | 14 | 0.220 |
Why?
|
Glucagon-Like Peptides | 1 | 2025 | 157 | 0.210 |
Why?
|
Cholinergic Antagonists | 1 | 2004 | 167 | 0.210 |
Why?
|
Receptors, Cholinergic | 1 | 2004 | 244 | 0.210 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2023 | 82 | 0.210 |
Why?
|
Dementia, Vascular | 1 | 2023 | 125 | 0.200 |
Why?
|
Tauopathies | 2 | 2024 | 328 | 0.190 |
Why?
|
Olfaction Disorders | 1 | 2024 | 225 | 0.190 |
Why?
|
Aged, 80 and over | 18 | 2025 | 59738 | 0.190 |
Why?
|
Aged | 30 | 2025 | 171790 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 890 | 0.180 |
Why?
|
alpha-Synuclein | 2 | 2024 | 774 | 0.180 |
Why?
|
Illness Behavior | 1 | 2019 | 23 | 0.170 |
Why?
|
Parkinsonian Disorders | 1 | 2023 | 285 | 0.170 |
Why?
|
Counseling | 2 | 2024 | 1554 | 0.170 |
Why?
|
Electroencephalography | 3 | 2024 | 6318 | 0.150 |
Why?
|
Primary Health Care | 3 | 2021 | 4748 | 0.150 |
Why?
|
Age of Onset | 1 | 2024 | 3346 | 0.140 |
Why?
|
Activities of Daily Living | 2 | 2022 | 2433 | 0.140 |
Why?
|
Thyroid Nodule | 1 | 2004 | 767 | 0.140 |
Why?
|
Memory Disorders | 4 | 2023 | 1203 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2003 | 878 | 0.140 |
Why?
|
Patient Care Planning | 2 | 2019 | 904 | 0.140 |
Why?
|
Double-Blind Method | 5 | 2025 | 12469 | 0.140 |
Why?
|
Functional Laterality | 1 | 2003 | 2269 | 0.140 |
Why?
|
Longitudinal Studies | 7 | 2024 | 14795 | 0.140 |
Why?
|
Data Collection | 3 | 2023 | 3322 | 0.130 |
Why?
|
Female | 34 | 2025 | 397464 | 0.130 |
Why?
|
Cerebrovascular Disorders | 1 | 2023 | 1486 | 0.130 |
Why?
|
Sequence Analysis, RNA | 1 | 2024 | 2041 | 0.130 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1672 | 0.130 |
Why?
|
Mental Disorders | 1 | 2016 | 6879 | 0.130 |
Why?
|
Male | 29 | 2025 | 365249 | 0.130 |
Why?
|
Headache | 1 | 2003 | 1263 | 0.120 |
Why?
|
Amyloidosis | 1 | 2022 | 879 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 10397 | 0.120 |
Why?
|
Scopolamine | 2 | 2005 | 93 | 0.120 |
Why?
|
Aging | 2 | 2012 | 8765 | 0.110 |
Why?
|
Middle Aged | 19 | 2025 | 223740 | 0.110 |
Why?
|
Intracranial Aneurysm | 1 | 2003 | 1293 | 0.110 |
Why?
|
Cerebral Hemorrhage | 1 | 2005 | 2660 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1008 | 0.110 |
Why?
|
Photic Stimulation | 3 | 2016 | 2003 | 0.100 |
Why?
|
Tacrine | 1 | 2011 | 4 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2017 | 1195 | 0.100 |
Why?
|
Databases, Bibliographic | 1 | 2012 | 129 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2663 | 0.090 |
Why?
|
Plaque, Amyloid | 3 | 2024 | 769 | 0.090 |
Why?
|
Mental Status Schedule | 1 | 2012 | 315 | 0.090 |
Why?
|
Reaction Time | 2 | 2016 | 2102 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2004 | 2360 | 0.090 |
Why?
|
Limbic Encephalitis | 1 | 2011 | 36 | 0.090 |
Why?
|
Neurofibrillary Tangles | 2 | 2024 | 459 | 0.090 |
Why?
|
Atrophy | 3 | 2023 | 1647 | 0.090 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2011 | 92 | 0.090 |
Why?
|
Evoked Potentials | 1 | 2016 | 1058 | 0.090 |
Why?
|
Face | 1 | 2016 | 1031 | 0.090 |
Why?
|
Prion Diseases | 1 | 2011 | 99 | 0.080 |
Why?
|
Hashimoto Disease | 1 | 2011 | 108 | 0.080 |
Why?
|
Accidental Falls | 1 | 2018 | 1080 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2339 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2012 | 6031 | 0.080 |
Why?
|
Apolipoprotein E4 | 2 | 2023 | 712 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2667 | 0.080 |
Why?
|
Oocytes | 1 | 1993 | 1172 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2527 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20244 | 0.080 |
Why?
|
Life Style | 1 | 2019 | 3931 | 0.070 |
Why?
|
Simvastatin | 1 | 2010 | 346 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2011 | 916 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8559 | 0.070 |
Why?
|
Encephalitis | 1 | 2011 | 441 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1364 | 0.070 |
Why?
|
Positron-Emission Tomography | 4 | 2024 | 6673 | 0.070 |
Why?
|
Time | 1 | 2008 | 552 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10778 | 0.060 |
Why?
|
Parahippocampal Gyrus | 1 | 2005 | 118 | 0.060 |
Why?
|
Muscarinic Antagonists | 1 | 2005 | 136 | 0.060 |
Why?
|
Aspirin | 1 | 2016 | 3135 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2763 | 0.060 |
Why?
|
Hemorrhage | 1 | 2016 | 3465 | 0.060 |
Why?
|
Learning | 2 | 2023 | 1761 | 0.060 |
Why?
|
Time Factors | 4 | 2021 | 40266 | 0.060 |
Why?
|
Neurogranin | 1 | 2023 | 15 | 0.060 |
Why?
|
Presenilin-2 | 1 | 2023 | 100 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13020 | 0.050 |
Why?
|
Suppuration | 1 | 2023 | 61 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2025 | 65485 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6346 | 0.050 |
Why?
|
Electrons | 1 | 2023 | 264 | 0.050 |
Why?
|
Brain Diseases | 1 | 2011 | 1558 | 0.050 |
Why?
|
Spouses | 1 | 2024 | 286 | 0.050 |
Why?
|
Ultrasonography | 2 | 2005 | 6001 | 0.050 |
Why?
|
Ehrlichia chaffeensis | 1 | 2000 | 3 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2913 | 0.050 |
Why?
|
Ehrlichiosis | 1 | 2000 | 28 | 0.040 |
Why?
|
Anticoagulants | 1 | 2016 | 4850 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3709 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 9081 | 0.040 |
Why?
|
Calcium | 1 | 1993 | 5792 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2011 | 5323 | 0.040 |
Why?
|
Presenilin-1 | 1 | 2023 | 665 | 0.040 |
Why?
|
Models, Psychological | 1 | 2003 | 826 | 0.040 |
Why?
|
Brain Stem | 1 | 2024 | 862 | 0.040 |
Why?
|
Patient Selection | 1 | 2011 | 4265 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2005 | 6242 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2003 | 1836 | 0.040 |
Why?
|
South America | 1 | 2018 | 180 | 0.040 |
Why?
|
Research Design | 2 | 2024 | 6213 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2023 | 1116 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1461 | 0.040 |
Why?
|
Drug Approval | 1 | 2024 | 820 | 0.040 |
Why?
|
Models, Biological | 1 | 1993 | 9499 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2021 | 645 | 0.030 |
Why?
|
Asia | 1 | 2018 | 629 | 0.030 |
Why?
|
Visual Perception | 1 | 2005 | 1407 | 0.030 |
Why?
|
Choice Behavior | 1 | 2023 | 848 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5864 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2003 | 1434 | 0.030 |
Why?
|
Facial Paralysis | 1 | 2000 | 346 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1003 | 0.030 |
Why?
|
Mexico | 1 | 2018 | 769 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2023 | 1728 | 0.030 |
Why?
|
Cohort Studies | 2 | 2024 | 41800 | 0.030 |
Why?
|
Preoperative Care | 1 | 2004 | 2258 | 0.030 |
Why?
|
Patient Participation | 1 | 2024 | 1448 | 0.030 |
Why?
|
Australia | 1 | 2018 | 1265 | 0.030 |
Why?
|
Nurses | 1 | 2005 | 2501 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2357 | 0.030 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1993 | 110 | 0.030 |
Why?
|
Photolysis | 1 | 1993 | 94 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 54950 | 0.030 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 1993 | 89 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2129 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 2030 | 0.030 |
Why?
|
Adolescent | 2 | 2016 | 89247 | 0.030 |
Why?
|
Biophysical Phenomena | 1 | 1993 | 320 | 0.030 |
Why?
|
Quality of Life | 2 | 2024 | 13510 | 0.030 |
Why?
|
Biophysics | 1 | 1993 | 379 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2008 | 5834 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2024 | 3580 | 0.020 |
Why?
|
Adult | 5 | 2016 | 223818 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2007 | 15471 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3441 | 0.020 |
Why?
|
Diffusion | 1 | 1993 | 818 | 0.020 |
Why?
|
Biological Clocks | 1 | 1993 | 321 | 0.020 |
Why?
|
Hydroxycholesterols | 1 | 2010 | 23 | 0.020 |
Why?
|
Cytosol | 1 | 1993 | 886 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3590 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 30044 | 0.020 |
Why?
|
Calcium Channels | 1 | 1993 | 624 | 0.020 |
Why?
|
Gene Expression | 1 | 2022 | 7602 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8742 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2016 | 1176 | 0.020 |
Why?
|
Xenopus laevis | 1 | 1993 | 966 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 1993 | 859 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9549 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8055 | 0.020 |
Why?
|
Kinetics | 1 | 1993 | 6334 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5455 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21545 | 0.010 |
Why?
|
Risk Factors | 2 | 2017 | 74971 | 0.010 |
Why?
|
United States | 2 | 2024 | 73180 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1145 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 972 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24330 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8095 | 0.010 |
Why?
|
HL-60 Cells | 1 | 2000 | 364 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30266 | 0.010 |
Why?
|
Granulocytes | 1 | 2000 | 551 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3411 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2359 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2000 | 1478 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2004 | 81892 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15875 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2016 | 15889 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6085 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2008 | 15955 | 0.010 |
Why?
|
Animals | 1 | 1993 | 169408 | 0.000 |
Why?
|